Compound Detail
CHEMBL6067492
BLEOMYCIN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
No structure available
Basic Information
| ChEMBL ID | CHEMBL6067492 |
| Name | BLEOMYCIN |
| Phase | Approved |
| Structure Type | NONE |
| Therapeutic | ✓ Yes |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
9
Known Names
20
Indications
Drug Information
| Molecule Type | Unknown |
| First Approval | 1973 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Indications
Neoplasms Neoplasms HIV Infections Hodgkin Disease Hodgkin Disease Lymphoma Lymphoma, Large B-Cell, Diffuse Ovarian Neoplasms Pericardial Effusion Seminoma Sex Cord-Gonadal Stromal Tumors Testicular Neoplasms Carcinoma, Squamous Cell Central Nervous System Neoplasms Head and Neck Neoplasms Lymphedema Lymphoma, T-Cell, Peripheral Neoplasms, Germ Cell and Embryonal Rectal Neoplasms Vulvar Neoplasms
ATC Classification
L01DC01
bleomycin
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ANTINEOPLASTIC AGENTS
Data from ChEMBL 36 via Core Engine